These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37370760)

  • 1. Childhood Cancer Survivors: An Overview of the Management of Late Effects.
    Argenziano M; Di Paola A; Rossi F
    Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Modifiable Health Conditions and Social Determinants of Health With Late Mortality in Survivors of Childhood Cancer.
    Ehrhardt MJ; Liu Q; Dixon SB; Caron E; Redd D; Shelton K; Huang IC; Bhakta N; Ness KK; Mulrooney DA; Brinkman TM; Chemaitilly W; Delaney A; Armstrong GT; Srivastava DK; Zaidi A; Robison LL; Yasui Y; Hudson MM
    JAMA Netw Open; 2023 Feb; 6(2):e2255395. PubMed ID: 36763361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of cancer registry and electronic health record data to construct a childhood cancer survivorship cohort, facilitate risk stratification for late effects, and assess appropriate follow-up care.
    Noyd DH; Neely NB; Schroeder KM; Lantos PM; Power S; Kreissman SG; Oeffinger KC
    Pediatr Blood Cancer; 2021 Jun; 68(6):e29014. PubMed ID: 33742534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline.
    Landier W; Bhatia S; Eshelman DA; Forte KJ; Sweeney T; Hester AL; Darling J; Armstrong FD; Blatt J; Constine LS; Freeman CR; Friedman DL; Green DM; Marina N; Meadows AT; Neglia JP; Oeffinger KC; Robison LL; Ruccione KS; Sklar CA; Hudson MM
    J Clin Oncol; 2004 Dec; 22(24):4979-90. PubMed ID: 15576413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe fatigue after treatment for childhood cancer.
    van Deuren S; Boonstra A; van Dulmen-den Broeder E; Blijlevens N; Knoop H; Loonen J
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012681. PubMed ID: 32124971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbidity Differences by Trajectory Groups as a Reference for Identifying Patients at Risk for Late Mortality in Childhood Cancer Survivors: Longitudinal National Cohort Study.
    Kim H; Kim HR; Kang SH; Koh KN; Im HJ; Park YR
    JMIR Public Health Surveill; 2023 Mar; 9():e41203. PubMed ID: 36754630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frailty and sarcopenia within the earliest national Dutch childhood cancer survivor cohort (DCCSS-LATER): a cross-sectional study.
    van Atteveld JE; de Winter DTC; Pluimakers VG; Fiocco M; Nievelstein RAJ; Hobbelink MGG; Kremer LCM; Grootenhuis MA; Maurice-Stam H; Tissing WJE; de Vries ACH; Loonen JJ; van Dulmen-den Broeder E; van der Pal HJH; Pluijm SMF; van der Heiden-van der Loo M; Versluijs AB; Louwerens M; Bresters D; van Santen HM; Hoefer I; van den Berg SAA; den Hartogh J; Hoeijmakers JHJ; Neggers SJCMM; van den Heuvel-Eibrink MM;
    Lancet Healthy Longev; 2023 Apr; 4(4):e155-e165. PubMed ID: 37003274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The crucial role of primary care providers in the long-term follow-up of adult survivors of childhood cancer.
    Jain J; Qorri B; Szewczuk MR
    Cancer Manag Res; 2019; 11():3411-3418. PubMed ID: 31118774
    [No Abstract]   [Full Text] [Related]  

  • 9. The EKZ/AMC childhood cancer survivor cohort: methodology, clinical characteristics, and data availability.
    Sieswerda E; Mulder RL; van Dijk IW; van Dalen EC; Knijnenburg SL; van der Pal HJ; Mud MS; Heinen RC; Caron HN; Kremer LC
    J Cancer Surviv; 2013 Sep; 7(3):439-54. PubMed ID: 23625157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frailty and quality of life in adult survivors of childhood cancer.
    Ness KK; Howell CR; Bjornard KL
    Expert Rev Qual Life Cancer Care; 2017; 2(2):79-85. PubMed ID: 28451645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiologic Frailty and Neurocognitive Decline Among Young-Adult Childhood Cancer Survivors: A Prospective Study From the St Jude Lifetime Cohort.
    Williams AM; Krull KR; Howell CR; Banerjee P; Brinkman TM; Kaste SC; Partin RE; Srivastava D; Yasui Y; Armstrong GT; Robison LL; Hudson MM; Ness KK
    J Clin Oncol; 2021 Nov; 39(31):3485-3495. PubMed ID: 34283634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutritional interventions for survivors of childhood cancer.
    Cohen JE; Wakefield CE; Cohn RJ
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD009678. PubMed ID: 27545902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the Childhood Cancer Survivor Study.
    Suh E; Stratton KL; Leisenring WM; Nathan PC; Ford JS; Freyer DR; McNeer JL; Stock W; Stovall M; Krull KR; Sklar CA; Neglia JP; Armstrong GT; Oeffinger KC; Robison LL; Henderson TO
    Lancet Oncol; 2020 Mar; 21(3):421-435. PubMed ID: 32066543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic late adverse effects after antineoplastic treatment for childhood cancer.
    Mulder RL; Bresters D; Van den Hof M; Koot BG; Castellino SM; Loke YKK; Post PN; Postma A; Szőnyi LP; Levitt GA; Bardi E; Skinner R; van Dalen EC
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD008205. PubMed ID: 30985922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Young Survivors at KSA: registry for standardised assessment of long-term and late-onset health events in survivors of childhood and adolescent cancer-a study protocol.
    Otth M; Drozdov D; Hügli C; Scheinemann K
    BMJ Open; 2021 Dec; 11(12):e053749. PubMed ID: 34862296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of cardiovascular late sequelae in long-term survivors of childhood cancer: A systematic review and meta-analysis.
    Scholz-Kreisel P; Spix C; Blettner M; Eckerle S; Faber J; Wild P; Merzenich H; Hennewig U
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28205419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician preferences and knowledge regarding the care of childhood cancer survivors in Japan: a mailed survey of the Japanese Society of Pediatric Oncology.
    Ishida Y; Takahashi M; Maru M; Mori M; Henderson TO; Daugherty CK; Manabe A
    Jpn J Clin Oncol; 2012 Jun; 42(6):513-21. PubMed ID: 22457322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development, testing, and preliminary feasibility of an adaptable pediatric oncology nutrition algorithm for low-middle income countries.
    Fleming CA; Viani K; Murphy AJ; Mosby TT; Arora B; Schoeman J; Ladas EJ
    Indian J Cancer; 2015; 52(2):225-8. PubMed ID: 26853414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study.
    Bhakta N; Liu Q; Yeo F; Baassiri M; Ehrhardt MJ; Srivastava DK; Metzger ML; Krasin MJ; Ness KK; Hudson MM; Yasui Y; Robison LL
    Lancet Oncol; 2016 Sep; 17(9):1325-34. PubMed ID: 27470081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer.
    Knijnenburg SL; Mulder RL; Schouten-Van Meeteren AY; Bökenkamp A; Blufpand H; van Dulmen-den Broeder E; Veening MA; Kremer LC; Jaspers MW
    Cochrane Database Syst Rev; 2013 Oct; (10):CD008944. PubMed ID: 24101439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.